1. 185O_PRSerum assessment of non-adherence to adjuvant endocrine therapy (ET) among premenopausal patients in the prospective multicenter CANTO cohort. (23rd October 2018) Authors: Pistilli, B; Paci, A; Michiels, S; Ferreira, A; Poinsignon, V; Cottu, P H; Lerebours, F; Coutant, C; Lesur, A; Tredan, O; Soulie, P; Vanlemmens, L; Jouannaud, C; Levy, C; Everhard, S; Arveux, P; Partridge, A H; Delaloge, S; André, F; Vaz-Luis, I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 93OImpact of tamoxifen (TAM) serum concentration on side effects among premenopausal patients (pts) with early breast cancer (BC) in the prospective multicenter CANTO cohort. (13th May 2019) Authors: Ferreira, A R; Paci, A; Meglio, A Di; André, F; Everhard, S; Martin, A-L; Fasse, L; Menvielle, G; Vaz-Luis, I; Pistilli, B Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Curcumin dietary supplements and everolimus-based cancer treatment. (3rd November 2017) Authors: Mir, O; Ropert, S; Chamseddine, A N; Paci, A Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗